Literature DB >> 11849252

Metastatic tumours of the adrenal glands: a 30-year experience in a teaching hospital.

K-Y Lam1, C-Y Lo.   

Abstract

OBJECTIVE: Adrenal metastases are frequently encountered during autopsy but uncommonly present clinically. The aim of this study was to evaluate the clinical and pathological impact of adrenal metastases in a large series of patients. PATIENTS: Four hundred and sixty-four patients (288 men, 176 women) with metastatic disease in the adrenal glands over a 30-year period were included in the study. MEASUREMENTS: The clinical records and pathological features were reviewed.
RESULTS: The frequencies of adrenal metastases at autopsies, adrenalectomies and fine-needle aspiration biopsies were 3.1%, 7.5% and 33%, respectively. The lesions were often seen in elderly patients (mean age, 62, SD = 13 years). Many of the metastatic lesions in the adrenal gland occurred shortly after the detection of a primary tumour (mean latent period = 7 months). Four per cent of the adrenal lesions (n = 20) were symptomatic. The symptomatic adrenal lesions, as compared with asymptomatic ones, were bigger and seen in younger patients. Five patients presented with adrenal insufficiency (Addison's disease) and one had massive peritoneal haemorrhage because of metastatic carcinoma. Ninety per cent (n = 421) of the metastatic adrenal tumours were carcinomas and 56% of these were adenocarcinoma. Lung was the most common primary tumour site (35%), followed by the stomach (14%), the oesophagus (12%) and the liver/bile ducts (10%). The adrenal metastases were bilateral in approximately half of the patients (49%, n = 229). The mean diameter of the adrenal metastases was 2 cm (SD = 1.9 cm). The mean weight of the right adrenal gland harbouring the metastasis was 19 g, while that of the left 20 g. The median survival of the 20 patients with symptomatic adrenal lesions was 3 months (range, 0-75 months) after the detection of adrenal metastases. Patients with surgically removed adrenal metastases had slightly better survival rates than those without surgical resection.
CONCLUSIONS: A variety of tumours may give rise to adrenal metastases. They are often asymptomatic and detected as part of multiorgan metastases. Symptomatic cases, albeit rare, may occur. Long-term survival may be achieved in selected patients in whom an aggressive surgical approach may be adopted.

Entities:  

Mesh:

Year:  2002        PMID: 11849252     DOI: 10.1046/j.0300-0664.2001.01435.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  110 in total

1.  Primary malignant melanoma of adrenal gland in a 41-yr-old woman.

Authors:  Attila Zalatnai; Béla Szende; Miklós Tóth; Károly Rácz
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

Review 2.  Review and uses of stereotactic body radiation therapy for oligometastases.

Authors:  Filippo Alongi; Stefano Arcangeli; Andrea Riccardo Filippi; Umberto Ricardi; Marta Scorsetti
Journal:  Oncologist       Date:  2012-06-20

3.  Addison's disease as a presentation of metastatic malignant melanoma.

Authors:  B Srinivasan; M Patel; M Ethunandan; V Ilankovan
Journal:  Ann R Coll Surg Engl       Date:  2016-01       Impact factor: 1.891

4.  Subacute cerebellar degeneration associated with calcitonin producing tumor.

Authors:  Damir Petravić; Mario Habek; Zdravko Perković; Jasna Franjić
Journal:  J Neurooncol       Date:  2006-01       Impact factor: 4.130

Review 5.  Addisonian crisis secondary to bilateral adrenal metastases in rectal carcinoma: report of a rare case and literature review.

Authors:  Muhammad Shahid Iqbal; John Hardman
Journal:  J Gastrointest Cancer       Date:  2013-06

6.  Adrenal metastectomy is safe in selected patients.

Authors:  Minerva Angelica Romero Arenas; Dawen Sui; Elizabeth G Grubbs; Jeffrey E Lee; Nancy D Perrier
Journal:  World J Surg       Date:  2014-06       Impact factor: 3.352

7.  Severe hyperkalemia and bilateral adrenal metastasis.

Authors:  Michael Nagler; Beat Müller; Verena Briner; Ralph Winterhalder
Journal:  J Oncol       Date:  2010-03-02       Impact factor: 4.375

8.  Calcitriol-mediated Reversible Hypercalcemia in a Patient with Primary Adrenal Lymphoma.

Authors:  Shahnaz Ahmad Mir; Shariq Rashid Masoodi; Arshad Iqbal Wani; Syed Nisar Ahmad; Iqra Hameed
Journal:  Malays J Med Sci       Date:  2016-12-07

9.  Tumor acquisition for biomarker research in lung cancer.

Authors:  Marvaretta Stevenson; Jared Christensen; Debra Shoemaker; Traci Foster; William T Barry; Betty C Tong; Momen Wahidi; Scott Shofer; Michael Datto; Geoffrey Ginsburg; Jeffrey Crawford; Thomas D'Amico; Neal Ready
Journal:  Cancer Invest       Date:  2014-05-09       Impact factor: 2.176

10.  Can single-phase dual-energy CT reliably identify adrenal adenomas?

Authors:  A Helck; N Hummel; F G Meinel; T Johnson; K Nikolaou; A Graser
Journal:  Eur Radiol       Date:  2014-05-08       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.